TickerFacts.

Xeris Biopharma Holdings, Inc. (XERS): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

172.74M
Year ended 2025-12-31
+8.4%
3-year compound annual growth
2021-12-31: 79.03M2022-12-31: 135.63M2023-12-31: 137.67M2024-12-31: 146.77M2025-12-31: 172.74M172.74M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31172.74M+17.7%2026-03-02, From 2025-01-01
2024-12-31146.77M+6.6%2026-03-02, From 2024-01-01
2023-12-31137.67M+1.5%2026-03-02, From 2023-01-01
2022-12-31135.63M+71.6%2025-03-06, From 2022-01-01
2021-12-3179.03Mn/a2024-03-06, From 2021-01-01